Posted by Eduardo Soares August 12, 2010 | 0 comment(s)
The worldwide life science community has been witnessing the emergence of many new biobusiness hotspots and the fast movement towards a truly global biotechnology industry. In this scenario, technology, people and capital will continue to be key success factors alongside the ability to leverage strategic partnerships and alliances, without borders. Latin America is well placed to be a major player and partner in building global value in the biobusiness arena. Life sciences in Latin America is now becoming a reality. After 20 years following and analyzing the market, especially in Brazil, what we see is a very positive scenario:
|
Related Report: |
Posted by Barbara Lavery August 05, 2010 | 3 comment(s)
One of the most successful social media campaigns to date has just made its run – and Old Spice is suddenly hip again. Those hilarious Old Spice Guy YouTube videos, corresponding Tweets, and 183 personal video responses posted on YouTube in a span of three days have vigorously turned the brand around. The campaign fueled Old Spice brand awareness with new audiences and led to a shocking sales increase of 107% in the past month alone! |
So, what has made this campaign so successful and what can biotech and pharma learn from it? Here are a few reasons why we think it worked so well ...
Posted by Jonathan Inman, Marketing Manager, TVG | July 15, 2010 | 0 comment(s)
As our team prepares for our Annual BioPartnering Europe conference in October, I find myself knee-deep in European biotech industry reports, BioCluster maps, newsletters, industry journals, news and analysis. Every communication piece and organization takes a slightly different angle on summing up the current state and future viability of our industry, but I find a common thread in each.
Unfortunately, the story doesn’t end here. Although the opportunities are promising there is opposition and it is fierce. |
Related Report: |
Posted by Robert Lee Kilpatrick June 10, 2010 | 0 comment(s)
I was recently at the 10th anniversary Bangalore INDIA Bio (BIB) conference and Exhibition in Bangalore, India. TVG launched its BioPartnering India conference as part of the BIB conference which attracted over 700 delegates and the exhibition was visited by over 6000 people. There is a lot of energy and enthusiasm and commitment for the biotech industry in India. To give you some idea of the scale of preparations that are being made for the growth of the biotech sector in India, each year the country produces over one million engineering graduates, and it is foreseen that India will harness this skill to develop products which span biotech (BT), information technology (IT), and devices. This awesome statistic was presented by Prof. Samir Kumar Brahmachari, Director General of the Counsel of Scientific Industrial Research (CSIR), who reports to the Indian Prime Minister and guides government biotech policy. Prof. Brahmachari in conversation, reported to me that India is committed to a rapid expansion of the biotech industry as a mechanism to lift millions of people out of poverty and transform India into a knowledge-based economy. The number one priority for the Indian government and many Indian families is education ...
Posted by Barbara Lavery May 05, 2010 | 3 comment(s)
Having watched and helped develop biotech company presentations for many years, I can recommend some basic rules of play that can help make your presentation the one that stands out. Every company has a different story to tell but mostly the presentations are in the same format, in the same room, and to the same people. So how can you be the one who stands out in the crowd?
Enthusiasm - if you don’t believe in your company why would anyone else? Be confident enough in your presentation to be able to present naturally and deal with any unforeseen technical issues.
“I watched a CEO present to a packed room of potential investors in New York. The projector started smoking at slide 3 and blew up at slide 5 - the CEO stepped forward as the projector was wheeled off stage right and continued unfazed.”
A memorable performance - this CEO knew his pitch so well and was so focused on delivering to his audience that even a flaming projector didn’t stop him ...
Posted by Rebecca Angelos April 21, 2010 | 0 comment(s)
During the last week of March, I conducted a site inspection for the newest TVG Global Platform destination, BioPartnering Latin America (BPL). After 15+ hours of airtime, I landed in beautiful Rio de Janeiro on Tuesday morning. The weather was sunny and beautiful as I traveled from the airport to the amazing Sofitel Hotel located on Copacabana Beach. Upon arrival, I was greeted by friendly staff who escorted me to my ocean view room. Later that afternoon, I met with Mr. Eduardo Emrich Soares, Biominas President & CEO, to discuss the progress of BPL. The meeting resulted in a better understanding of our newest Collaborators and Sponsors and their contributions to the BPL program.
The remaining two days consisted of logistical meetings with the hotel staff and Ms. Angélica Patarroyo, Biominas Communication & Marketing Coordinator for BPL. I did manage to take a couple of hours and see parts of Rio de Janeiro. First, we visited Sugarloaf Mountain, which is located 1,299 feet (396 meters) above the harbor at the mouth of Guanabara Bay on a peninsula that sticks out into the Atlantic Ocean.
The second site was the Maracanã stadium, the largest stadium in South America, currently seating over 90,000 spectators. It has mainly been used for football (soccer) matches between the major football (soccer) clubs in Rio de Janeiro. This stadium will be the centerpiece of the 2016 Summer Olympics and Paralympics and will host the FIFA World Cup in 2014.
Upon departing on Thursday evening, I reflected on the immense progress we have made towards BPL 2010, since we began planning this event over 18 months ago. BioPartnering Latin America will showcase the entire region from Mexico to Chile, Brazil, and Argentina. The focus of BPL 2010 will be human, animal and plant health, highlighting a fast growing sector of innovative Latin America companies and presenting significant partnering opportunities. BPL will be held on September 19-21, 2010, in Rio, just across from the Copacabana Beach. I look forward to seeing you there!
Posted by Robert Lee Kilpatrick January 22, 2010 | 0 comment(s)
TVG is strongly committed to advantage India and for the second year we are working closely with Bangalore India Bio, the largest and best showcase of the Indian life science industry. We are pleased to be collaborating with MMActiv, the Vision Group on Biotechnology, ABLE and other leaders of the Indian life science industry.
On January 19th, Biocon Chairman & Managing Director Kiran Mazumdar-Shaw gathered with industry leaders for the “Curtain Raising” to announce Bangalore India Bio 2010 and to promote the growth of India’s biotech industry. (see photos of the event below)
Kiran Mazumdar-Shaw is a leading figure in India’s biotech industry and predicts that biotechnology will grow to a $5 billion business in India by next year and then double to $10 billion by the year 2015. There is no question that India provides the opportunity for rapid growth and affordable innovation.
This year TVG will produce BioPartnering India @ Bangalore India Bio, June 2-4, 2010. BioPartnering India will showcase the best life science partnering opportunities in India, as well as enable foreign companies to present to an Indian audience. India offers a bright future for biotech and pharmaceutical companies and BioPartnering India represents TVG’s long-term commitment to India, its talented people and rich scientific culture.
Join me at BioPartnering India @ Bangalore India Bio to experience first hand all that India has to offer you and your company. India is indeed the destination for affordable innovation. See you there!
Posted by Brendan Payne January 13, 2010 | 0 comment(s)
Over the next month, the global spotlight will shine on Vancouver in the lead up to the 2010 Olympic Winter Games, but just prior to that, we look forward to having the attention of the biotech world turned to us to mark BioPartnering North America’s (BPN) eighth year. BPN is proudly produced by TVG and Life Sciences British Columbia (LSBC), and since its inception in 2003, we have worked together to lead the effort to build BPN into the largest stand-alone biotech partnering event in North America, and one of the leading biotech partnering conferences in the world – an accomplishment that LifeSciences BC takes great pride in.
LifeSciences BC works actively to raise the local, national and international profile of the innovative companies and research institutions that make up British Columbia’s leading-edge life sciences industry. These efforts have indirectly led to major international exposure, significant investments and partnering deals that have produced some of the world’s most prominent biotechnology pioneers including QLT Inc., Angiotech Pharmaceuticals and OncoGenex Technologies. BioPartnering North America serves not only to highlight British Columbia’s home-grown excellence in innovation, but to showcase all of the emerging opportunities throughout the international life science community and, from that awareness, to forge new relationships in a fashion consistent with British Columbia’s culture of achieving synergy through shared diversity and perspectives ...
Posted by Robert Lee Kilpatrick January 07, 2010 | 3 comment(s)
On January 7th, 1992, TVG opened for business and started planning for the first BioPartnering™ conference in London to encourage partnering between US and European life science companies. Today, as we celebrate TVG’s 18th birthday, BioPartnering, which was merely a concept before 1992, is a truly global activity and the catalyst for growth and innovation in our industry. We have witnessed tremendous change in our industry over these 18 years and we know that what we have experienced to date is only a shadow of the innovation and growth that we will realize over the next two decades.
In contrast to this incredible change, our mission at TVG remains the same. Since our inception, our goal has been to build and expand networks for the life science industry, which are dedicated to developing novel solutions in the areas of human, animal and plant health; food; energy; materials; and various industrial processes which will contribute to a new sustainable global economy in the 21st century. This is termed the “bio-economy” – an economy based on the use of living systems. In contrast, the petroleum-based economy is based on extracting non-renewable energy from the earth. The most effective way to grow and develop the companies that will usher in the bio-economy is by using networks to tap global innovation. TVG has been doing this for nearly 20 years and now a critical mass of players has arisen around the world, creating a need for a new kind of network ...
Posted by Jaro Dockalova December 18, 2009 | 0 comment(s)
The company profile is a research tool that helps delegates research and find companies to do business with. A company profile will leverage your presence at the conference and acts as an effective marketing tool. Your company’s success and competitiveness depends, in part, on easy access to information, insight and resources about your company. Uploading a profile and keeping it up-to-date will help you accomplish this. It is important for you to make your identity known so that potential partners have a chance to prospect and research your product or services.
Profile Pointers:
1. Don’t cut and paste your entire website
- You can include a link to your website; those that wish to learn more can click on the link. Pasting your entire website into the profile or having an out of date profile will turn off your readers.
- Help the reader grasp the key points. Briefly describe what your company/organization does using clear and concise phrases. Also, break up your paragraphs into easy to follow sections ...
Posted by Robert Lee Kilpatrick December 01, 2009 | 0 comment(s)
On October 12, 2009, TVG LLC, launched the world’s first Global BioPartnering Platform in London. This new network allows life science companies to access global innovation, raise new sources of capital, and tap into skilled workforces around the world. We have focused on six of the most important markets for life science companies, including USA/Canada, Europe, India, China, and Latin America. The Global BioPartnering Platform video is available to view below:
Posted by Rebecca Angelos November 23, 2009 | 0 comment(s)
9 Leading Pharmaceutical companies – Amgen, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Takeda – presented corporate strategies and partnering opportunities at BioPartnering Europe™ 2009 (BPE).
Year after year, TVG’s customers attend BPE to network with potential partners, join interactive discussions with industry leaders, and most importantly to get business done. Face-to-face partnering is so critical to the growth of life science companies that many of our attendees are booked solid with back-to-back meetings throughout the 3-day conference. Naturally, there are presentations and sessions that delegates must miss because of an important meeting or conflicting session.
For those of you who missed BPE this year and for those who attended but were booked solid with face-to-face meetings we are pleased to offer you audio recordings from each of the leading Pharmaceutical company presentations given at BPE 2009 ...
Posted by Susan Aldridge Ph.D. October 14, 2009 | 1 comment(s)
BIOFORECASTER, which has a panel of leading investors review the biotech scene, is arguably the most popular session at BioPartnering Europe. Delegates know they must earn their farewell drinks by listening to the experts’ predictions for the year ahead.
‘You cannot catch flies with vinegar,’ observed Antoine Papiernik (Managing Partner, Sofinnova). Translated, that probably means that you must put the right amount of money ( ie a large amount) into a biotech investment to realise its fruits. Sofinnova apparently likes to do this by stealth – a trend that was picked up on by private investor Andy Richards ‘With stealth investment there’s no website, no PR – but there’s a lot more money going in than people realise’ he observed.
Stealth investment notwithstanding, a great deal can still be achieved by investing relatively small amounts – Richards cited Abcam, Cambridge Labs and DXS as examples. ‘These are very diverse business models – and I think we ought to celebrate diversity more than we do,’ he said, This capital efficiency could become a watchword in tough economic times and, indeed, John Hodgson (Director, Critical i Ltd) wondered why we had put up with ‘capital stupidity’ for so long.
Looking forward, Hodgson was betting on US regulations on biosimilars by the end of the year (having noticed ‘runes pointing in the right direction’). He also predicted ‘more efficient’ IP gathering. Papiernik thought there’d be a ‘few’ IPOs soon and also warned that it was time people got up to date on China (after all Sinopharm has raised a billion dollars). He believes that Chinese pharmas will start buying up companies in the US and Europe – a strong signal of the nation’s gathering power. The comment was particularly apt – for BIOFORECASTER marked the start of BioPartnering China in the same venue on the following day ...
Posted by Robert Lee Kilpatrick October 05, 2009 | 0 comment(s)
The phrase “Think Globally, Act Locally”, was originated by the French-American microbiologist and humanist Rene Jules Dubos, as an adviser to the United Nations Conference on the Human Environment in 1972. In addressing the issue of ecological consciousness, he suggested that there needed to be the creation of a World Order in which “natural and social units maintain or recapture their identity, yet interplay with each other through a rich system of communications.”
Over 35 years later, the world is at a turning-point, with global warming, rapid human population growth, food security issues, and the steady erosion of the earth’s ecosystem, all requiring novel sustainable economic solutions. There is no shortage of good ideas, and now is the time to make it easier for people to work together to solve problems which affect all life on earth. The photo of earth taken by Apollo 17 in December of 1972 makes us realize that there is no special first class cabin to which the privileged few may retreat. We sink or swim together, and together we can make a go at finding solutions. TVG is playing an active and dynamic role in helping solve these problems via our social network. Dynamic new businesses and industries will arise from this immediate need.
TVG specializes in building and maintaining social networks for the life science industry, which are dedicated to developing novel solutions in the areas of human, animal and plant health; food; energy; materials; various industrial processes which will contribute to a new sustainable global economy in the 21st century. This is termed the “bio-economy” – an economy based on the use of living systems. In contrast, the petroleum-based economy is based on extracting non-renewable energy from the earth. The most effective way to grow and develop the companies that will create the bio-economy is by using social networks to tap global innovation - as Dubos pointed out, using a rich system of communications. TVG has been doing this for nearly 20 years and now a critical mass of players has arisen around the world, creating a need for a new kind of social network ...
Posted by Robert Lee Kilpatrick September 28, 2009 | 0 comment(s)
The term innovation refers to a new way of doing something. It may refer to incremental and emergent or radical and revolutionary changes in thinking, products, processes, or organizations. Following Schumpeter (1934), contributors to the scholarly literature on innovation typically distinguish between invention, an idea made manifest, and innovation, ideas applied successfully in practice. In many fields, something new must be substantially different to be innovative, not an insignificant change, e.g., in the arts, economics, business and government policy. In economics the change must increase value, customer value, or producer value. The goal of innovation is positive change, to make someone or something better. Innovation leading to increased productivity is the fundamental source of increasing wealth in an economy. Source: Wikipedia
The single most important human activity that has allowed us to evolve as a social species has been innovation, or as Darwin demonstrated in his work on natural selection, the power of living beings to adapt. In his two major works, On The Origin of Species (1859) and The Descent of Man, and Selection in Relation to Sex (1871), he demonstrates the ability of living creatures to change in response to new conditions of life, but also the ability to change the environment to suit the organism. In the past five thousand years, through innovation, human beings have increasingly changed the earth in order to support a dramatic and rapid population expansion, and in this process we have created highly differentiated civilizations. Now, innovation is in us: it is a part of what it means to be human.
How people express themselves innovatively depends on the culture in which they live. Comparing the USA, China, and the EU – the world’s leading innovation engines – offers some interesting insights ...